Trial Profile
Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic retinopathy
- Focus Adverse reactions
- Acronyms ACT
- 20 Apr 2016 Status changed from recruiting to completed.
- 26 Mar 2013 New trial record